Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ann Thor

Concepts (458)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
72
2023
2365
3.930
 Why?
Neoplasms, Germ Cell and Embryonal
8
2026
76
2.650
 Why?
Testicular Neoplasms
8
2026
111
2.620
 Why?
Metformin
10
2018
320
2.010
 Why?
Lymph Node Excision
6
2026
173
1.780
 Why?
Tamoxifen
11
2023
191
1.610
 Why?
Receptors, Estrogen
17
2020
400
1.460
 Why?
Thyroid Hormones
2
2023
68
1.400
 Why?
Seminoma
3
2026
20
1.340
 Why?
Biomarkers, Tumor
17
2024
1319
1.220
 Why?
Receptor, ErbB-3
8
2016
48
1.220
 Why?
Lymphatic Metastasis
18
2024
334
1.190
 Why?
Cell Proliferation
16
2023
2489
1.180
 Why?
Genes, erbB-2
8
2013
31
1.030
 Why?
Cell Cycle
5
2023
595
1.020
 Why?
Mammary Neoplasms, Experimental
6
2017
62
0.990
 Why?
MicroRNAs
6
2024
689
0.890
 Why?
Apoptosis
21
2018
2397
0.870
 Why?
Estrogen Receptor alpha
3
2023
151
0.840
 Why?
Estrogens
2
2023
364
0.760
 Why?
Cell Line, Tumor
23
2023
3523
0.750
 Why?
ErbB Receptors
6
2010
632
0.640
 Why?
Up-Regulation
3
2020
848
0.630
 Why?
Hormone Replacement Therapy
1
2020
107
0.600
 Why?
Immunohistochemistry
26
2020
1705
0.590
 Why?
Mammary Neoplasms, Animal
3
2018
34
0.570
 Why?
Triple Negative Breast Neoplasms
3
2016
217
0.560
 Why?
Caspases
5
2009
229
0.540
 Why?
Disease-Free Survival
11
2020
768
0.540
 Why?
Tumor Suppressor Protein p53
14
2011
532
0.510
 Why?
Retroperitoneal Space
3
2026
18
0.500
 Why?
Gene Expression Regulation, Neoplastic
18
2021
1437
0.480
 Why?
Antineoplastic Agents
10
2018
2201
0.470
 Why?
Prognosis
21
2020
4312
0.470
 Why?
Claudins
1
2016
22
0.460
 Why?
Receptor, IGF Type 1
3
2016
63
0.450
 Why?
Drug Resistance, Neoplasm
10
2023
881
0.440
 Why?
Trastuzumab
8
2016
117
0.420
 Why?
Quinazolines
3
2026
266
0.410
 Why?
Transcriptome
1
2020
1036
0.410
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2015
1961
0.410
 Why?
Carcinogenesis
1
2016
227
0.400
 Why?
Carcinoma, Ductal, Breast
5
2002
88
0.400
 Why?
Signal Transduction
16
2023
5185
0.400
 Why?
Postoperative Complications
1
2026
2950
0.390
 Why?
Estradiol
2
2009
507
0.380
 Why?
Genistein
2
2010
13
0.380
 Why?
Humans
95
2026
144667
0.380
 Why?
Receptors, Steroid
2
2012
41
0.370
 Why?
Hypoglycemic Agents
3
2017
1388
0.360
 Why?
Female
69
2026
78304
0.350
 Why?
Doxorubicin
10
2011
398
0.350
 Why?
Antineoplastic Agents, Hormonal
5
2020
192
0.340
 Why?
Antimetabolites, Antineoplastic
1
2012
105
0.340
 Why?
Receptors, Progesterone
6
2020
243
0.330
 Why?
Sweden
3
2026
111
0.320
 Why?
Teratoma
2
2022
124
0.310
 Why?
STAT3 Transcription Factor
1
2012
205
0.310
 Why?
Neoplasm Invasiveness
7
2016
503
0.310
 Why?
Genes, p53
5
2000
67
0.310
 Why?
Neoplasm Staging
9
2024
1465
0.310
 Why?
Mice
18
2023
18261
0.300
 Why?
Neoplasm Proteins
5
2016
441
0.290
 Why?
Glucose
1
2013
1033
0.270
 Why?
Middle Aged
33
2026
35971
0.270
 Why?
Glycoproteins
2
2005
353
0.270
 Why?
Intracellular Signaling Peptides and Proteins
2
2010
454
0.260
 Why?
Mammary Tumor Virus, Mouse
2
2004
42
0.260
 Why?
Mice, Transgenic
8
2018
2184
0.250
 Why?
MCF-7 Cells
4
2020
132
0.240
 Why?
Carcinoma
4
1995
224
0.240
 Why?
Animals
23
2023
37948
0.240
 Why?
Ejaculation
1
2026
11
0.240
 Why?
Neoplasm, Residual
2
2024
139
0.240
 Why?
Antibodies, Monoclonal
7
2013
1505
0.230
 Why?
Bromodeoxyuridine
2
1999
77
0.230
 Why?
Thiophenes
1
2026
121
0.220
 Why?
Multivariate Analysis
8
2005
1537
0.220
 Why?
Predictive Value of Tests
6
2024
2117
0.220
 Why?
Polymerase Chain Reaction
6
2021
1047
0.220
 Why?
Protein Kinase Inhibitors
3
2016
971
0.220
 Why?
Intraoperative Complications
1
2026
157
0.210
 Why?
Enzyme Activation
4
2009
762
0.210
 Why?
Tyrosine
2
2007
219
0.210
 Why?
Radiation Tolerance
1
2005
103
0.210
 Why?
Xenograft Model Antitumor Assays
3
2020
925
0.210
 Why?
Phosphorylation
5
2011
1704
0.200
 Why?
Cocarcinogenesis
1
2003
13
0.200
 Why?
Isoflavones
1
2003
25
0.200
 Why?
Cell Survival
5
2018
1092
0.200
 Why?
Survival Analysis
8
2005
1370
0.200
 Why?
Adult
22
2026
40489
0.190
 Why?
Paclitaxel
4
2015
256
0.190
 Why?
Chromosomes
1
2003
108
0.190
 Why?
Fluorouracil
6
2026
234
0.180
 Why?
Ki-67 Antigen
4
2014
117
0.180
 Why?
Cyclins
2
2000
79
0.180
 Why?
Chromosomes, Human, Pair 8
1
2002
38
0.180
 Why?
Gelsolin
1
2001
10
0.170
 Why?
Chromosome Aberrations
1
2002
164
0.170
 Why?
Orchiectomy
1
2021
73
0.170
 Why?
Cyclophosphamide
7
2011
265
0.170
 Why?
Proto-Oncogene Proteins c-ets
2
2020
56
0.170
 Why?
Breast
4
2018
157
0.170
 Why?
Retroperitoneal Neoplasms
1
2021
28
0.170
 Why?
Rats
7
2022
5570
0.160
 Why?
Caspase 3
4
2006
234
0.160
 Why?
Diet
3
2018
1270
0.160
 Why?
DNA-Binding Proteins
3
2020
1484
0.160
 Why?
Etoposide
1
2001
168
0.160
 Why?
Cell Division
6
2005
753
0.160
 Why?
Obesity
4
2022
3070
0.160
 Why?
Neoplastic Stem Cells
2
2014
407
0.160
 Why?
Mice, SCID
1
2020
368
0.150
 Why?
Phosphatidylinositol 3-Kinases
3
2011
380
0.150
 Why?
Transcription Factors
3
2020
1726
0.150
 Why?
Proto-Oncogene Proteins
5
2008
619
0.150
 Why?
Drug Screening Assays, Antitumor
3
2016
190
0.150
 Why?
TOR Serine-Threonine Kinases
3
2012
452
0.150
 Why?
Treatment Outcome
6
2026
11735
0.150
 Why?
Prospective Studies
4
2024
7994
0.150
 Why?
Carcinoma, Papillary
1
1999
77
0.150
 Why?
Mitotic Index
1
1999
25
0.150
 Why?
Mice, Inbred NOD
1
2020
610
0.140
 Why?
Receptors, Androgen
2
2017
148
0.140
 Why?
Antigens, Neoplasm
2
2009
272
0.140
 Why?
Chemotherapy, Adjuvant
5
2015
427
0.140
 Why?
Tumor Cells, Cultured
6
2009
881
0.140
 Why?
Aromatase
1
2018
32
0.140
 Why?
Ovarian Neoplasms
4
1995
589
0.140
 Why?
Drug Synergism
3
2018
352
0.140
 Why?
Kaplan-Meier Estimate
1
2020
967
0.130
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
58
0.130
 Why?
HSP90 Heat-Shock Proteins
1
2018
46
0.130
 Why?
Colorectal Neoplasms
1
2026
849
0.130
 Why?
Phenylthiohydantoin
2
2017
44
0.130
 Why?
Down-Regulation
3
2010
616
0.130
 Why?
Autism Spectrum Disorder
1
2023
410
0.130
 Why?
In Situ Hybridization, Fluorescence
4
2008
323
0.130
 Why?
Ovariectomy
4
2022
163
0.130
 Why?
Tumor Burden
4
2022
324
0.130
 Why?
Poly(ADP-ribose) Polymerases
2
2009
85
0.130
 Why?
Organic Cation Transport Proteins
1
2017
25
0.130
 Why?
Postmenopause
5
2022
390
0.120
 Why?
Triazoles
1
2018
184
0.120
 Why?
Antibodies, Monoclonal, Humanized
5
2013
990
0.120
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
230
0.120
 Why?
Smad Proteins
1
2016
43
0.120
 Why?
Cathepsin D
2
2002
18
0.120
 Why?
Gene Knock-In Techniques
1
2016
60
0.120
 Why?
Calcitriol
1
2016
57
0.120
 Why?
Ovary
1
2017
226
0.110
 Why?
Antibiotics, Antineoplastic
3
2009
139
0.110
 Why?
Proteins
2
1992
1016
0.110
 Why?
Male
9
2026
72431
0.110
 Why?
Gene Amplification
2
2009
119
0.110
 Why?
Protein Tyrosine Phosphatases
1
2016
167
0.110
 Why?
Fatty Acid Synthase, Type I
1
2014
11
0.110
 Why?
Immunoradiometric Assay
1
1994
1
0.110
 Why?
Immunoprecipitation
2
2011
147
0.100
 Why?
Mental Disorders
1
2023
1154
0.100
 Why?
Androgen Receptor Antagonists
1
2014
35
0.100
 Why?
Young Adult
4
2024
14122
0.100
 Why?
Disease Progression
6
2018
2847
0.100
 Why?
Postpartum Period
2
2014
368
0.100
 Why?
Insulin-Like Growth Factor I
1
2016
317
0.100
 Why?
Mice, Knockout
1
2020
3109
0.100
 Why?
Receptor, ErbB-4
2
2010
18
0.100
 Why?
Androgen Antagonists
1
2014
92
0.100
 Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2010
64
0.100
 Why?
Retrospective Studies
5
2026
17149
0.100
 Why?
Transforming Growth Factor beta
1
2016
475
0.100
 Why?
Blotting, Western
3
2011
1161
0.090
 Why?
Aged
15
2026
25955
0.090
 Why?
Adenocarcinoma
3
2012
923
0.090
 Why?
Vitamin D
1
2016
400
0.090
 Why?
Overnutrition
1
2012
28
0.090
 Why?
Nucleic Acid Hybridization
2
2003
186
0.090
 Why?
DNA, Neoplasm
6
2005
158
0.090
 Why?
Aminosalicylic Acids
1
2012
9
0.090
 Why?
Benzenesulfonates
1
2012
22
0.090
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
1992
61
0.090
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
238
0.090
 Why?
Gene Expression Profiling
2
2016
1766
0.090
 Why?
Chromones
1
2011
42
0.090
 Why?
Genital Diseases, Female
1
1991
31
0.090
 Why?
RNA, Messenger
4
2016
2815
0.090
 Why?
Disease Models, Animal
4
2017
4539
0.090
 Why?
Dasatinib
1
2011
57
0.080
 Why?
Fluoxymesterone
1
1991
1
0.080
 Why?
Apoptosis Regulatory Proteins
1
2012
185
0.080
 Why?
Proportional Hazards Models
4
2005
1322
0.080
 Why?
Mitosis
3
2001
200
0.080
 Why?
S Phase
2
2010
80
0.080
 Why?
Thiazoles
1
2011
139
0.080
 Why?
Reagent Kits, Diagnostic
1
1991
34
0.080
 Why?
Morpholines
1
2011
129
0.080
 Why?
Cohort Studies
2
2020
5957
0.080
 Why?
Weight Gain
3
2022
557
0.080
 Why?
Chromosomes, Human, Pair 17
3
2002
53
0.080
 Why?
Proto-Oncogenes
1
1989
28
0.080
 Why?
Genital Neoplasms, Female
1
1991
99
0.080
 Why?
Neoplasm Metastasis
5
2005
691
0.080
 Why?
Radioisotopes
1
1989
37
0.080
 Why?
Dose-Response Relationship, Drug
2
2008
2019
0.080
 Why?
Flow Cytometry
3
2007
1154
0.080
 Why?
Anthracyclines
1
2009
49
0.070
 Why?
DNA Topoisomerases, Type II
1
2009
47
0.070
 Why?
Follow-Up Studies
5
2020
5414
0.070
 Why?
Aged, 80 and over
6
2002
8284
0.070
 Why?
Gene Deletion
2
2002
392
0.070
 Why?
MAP Kinase Signaling System
1
2010
306
0.070
 Why?
AMP-Activated Protein Kinases
1
2009
191
0.070
 Why?
Epithelial Cells
1
2014
1106
0.070
 Why?
RNA, Small Interfering
2
2007
631
0.070
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
973
0.070
 Why?
Pyrimidines
1
2011
519
0.070
 Why?
Mice, Nude
1
2009
677
0.070
 Why?
Gene Dosage
1
2008
148
0.070
 Why?
Mutation
3
1995
4081
0.060
 Why?
Protein Structure, Tertiary
1
2009
849
0.060
 Why?
Reproducibility of Results
3
2023
3414
0.060
 Why?
Immunoenzyme Techniques
3
1999
197
0.060
 Why?
Time Factors
4
2015
7140
0.060
 Why?
Energy Metabolism
1
2012
927
0.060
 Why?
Proto-Oncogene Proteins c-akt
3
2016
435
0.060
 Why?
Enzyme Precursors
1
2006
15
0.060
 Why?
Thymidylate Synthase
1
2026
13
0.060
 Why?
Cell Nucleus
4
2006
592
0.060
 Why?
Aging
4
2003
1938
0.060
 Why?
Receptor, Notch1
1
2006
63
0.060
 Why?
Multigene Family
2
2003
210
0.060
 Why?
Lamin Type B
1
2005
6
0.060
 Why?
Epigenesis, Genetic
1
2010
669
0.060
 Why?
Herpes Simplex
1
2006
98
0.060
 Why?
Mitochondria
3
2008
984
0.060
 Why?
Herpesvirus 1, Human
1
2006
84
0.050
 Why?
Survival Rate
4
2020
2089
0.050
 Why?
Cell Nucleolus
1
2005
19
0.050
 Why?
Age Factors
3
2003
3329
0.050
 Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2007
106
0.050
 Why?
Benzamides
2
2017
224
0.050
 Why?
Antineoplastic Agents, Phytogenic
2
2007
176
0.050
 Why?
Nitriles
2
2017
205
0.050
 Why?
Feedback
1
2005
181
0.050
 Why?
RNA Interference
3
2015
473
0.050
 Why?
Protein Kinases
1
2006
314
0.050
 Why?
Tacrolimus Binding Protein 1A
1
2003
10
0.050
 Why?
Tumor Microenvironment
2
2018
729
0.050
 Why?
Tacrolimus Binding Proteins
1
2003
25
0.050
 Why?
Rats, Wistar
2
2017
449
0.050
 Why?
Mice, Inbred Strains
1
2004
396
0.050
 Why?
Estrogens, Non-Steroidal
1
2003
10
0.050
 Why?
Genes, Tumor Suppressor
1
2003
85
0.050
 Why?
Phytoestrogens
1
2003
17
0.050
 Why?
Adipose Tissue
2
2018
643
0.050
 Why?
Estrogen Antagonists
1
2003
37
0.050
 Why?
Plant Preparations
1
2003
37
0.050
 Why?
Cell Line
2
2003
2821
0.050
 Why?
Actins
1
2005
421
0.050
 Why?
Anticarcinogenic Agents
1
2003
61
0.050
 Why?
Chromosome Banding
1
2002
17
0.050
 Why?
Chromosomes, Human, Pair 16
1
2002
35
0.050
 Why?
Mammary Glands, Animal
1
2003
128
0.050
 Why?
Embryoid Bodies
1
2022
8
0.050
 Why?
Transfection
3
2015
924
0.050
 Why?
Rodentia
1
2022
62
0.040
 Why?
3' Untranslated Regions
2
2014
150
0.040
 Why?
Trefoil Factor-1
2
1992
2
0.040
 Why?
Fallopian Tubes
2
1991
31
0.040
 Why?
alpha-Fetoproteins
1
2021
42
0.040
 Why?
In Situ Nick-End Labeling
1
2001
120
0.040
 Why?
Chorionic Gonadotropin
1
2021
77
0.040
 Why?
RNA, Catalytic
1
2002
190
0.040
 Why?
Nuclear Proteins
2
2000
741
0.040
 Why?
DNA Fragmentation
1
2001
39
0.040
 Why?
Inhibitory Concentration 50
1
2001
90
0.040
 Why?
Plasmids
1
2002
375
0.040
 Why?
Fibrosis
1
2023
547
0.040
 Why?
Antigens, Nuclear
1
2000
15
0.040
 Why?
RNA Stability
1
2021
119
0.040
 Why?
Breast Diseases
1
2000
23
0.040
 Why?
Enhancer Elements, Genetic
1
2000
192
0.040
 Why?
Integrin beta3
2
2013
14
0.040
 Why?
Tumor Suppressor Proteins
2
1992
319
0.040
 Why?
Telomerase
1
2001
249
0.040
 Why?
N-Glycosyl Hydrolases
1
1998
6
0.040
 Why?
Methylnitrosourea
1
2018
7
0.040
 Why?
DNA Glycosylases
1
1998
10
0.040
 Why?
Loss of Function Mutation
1
2018
46
0.030
 Why?
G2 Phase Cell Cycle Checkpoints
1
2018
44
0.030
 Why?
Antibodies
1
2000
396
0.030
 Why?
Trans-Activators
1
2000
397
0.030
 Why?
NF-kappa B
1
2002
657
0.030
 Why?
Codon
3
1993
93
0.030
 Why?
Half-Life
1
2018
152
0.030
 Why?
Case-Control Studies
2
2023
3603
0.030
 Why?
Stromal Cells
1
2018
120
0.030
 Why?
Hyaluronan Receptors
1
1998
104
0.030
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
165
0.030
 Why?
Gene Expression
3
2013
1476
0.030
 Why?
Organic Cation Transporter 2
1
2017
8
0.030
 Why?
Cell Movement
1
2001
959
0.030
 Why?
Extracellular Matrix Proteins
1
1998
156
0.030
 Why?
Steroids
1
2017
159
0.030
 Why?
Proto-Oncogene Proteins pp60(c-src)
1
2016
14
0.030
 Why?
Antigens, CD
2
2014
552
0.030
 Why?
DNA Repair
1
1998
256
0.030
 Why?
Oncogenes
1
2016
118
0.030
 Why?
Chromatography, Liquid
1
2017
444
0.030
 Why?
Phosphatidylinositol 3-Kinase
1
2015
24
0.030
 Why?
Oncogene Proteins
1
1995
61
0.030
 Why?
Analysis of Variance
2
2014
1301
0.030
 Why?
RNA
1
2001
926
0.030
 Why?
Homeodomain Proteins
1
2018
523
0.030
 Why?
Tosyl Compounds
1
2014
16
0.030
 Why?
Gene Expression Regulation, Enzymologic
1
2015
268
0.030
 Why?
Mammary Glands, Human
1
2014
68
0.030
 Why?
Integrin alpha6
1
2013
9
0.030
 Why?
Mass Spectrometry
1
2017
743
0.030
 Why?
Leukocyte Common Antigens
1
2014
87
0.030
 Why?
Adolescent
3
2024
22409
0.030
 Why?
Antigens, Differentiation, Myelomonocytic
1
2014
65
0.030
 Why?
Parity
1
2014
108
0.030
 Why?
Neovascularization, Pathologic
1
1995
284
0.020
 Why?
Immunoassay
1
1994
105
0.020
 Why?
Premenopause
1
2014
123
0.020
 Why?
Anilides
1
2014
84
0.020
 Why?
Transplantation, Heterologous
1
2014
169
0.020
 Why?
Neoplasm Transplantation
1
2014
246
0.020
 Why?
Testosterone
1
2017
412
0.020
 Why?
Tomography, X-Ray Computed
1
2024
2754
0.020
 Why?
bcl-2-Associated X Protein
2
2007
52
0.020
 Why?
Sirolimus
2
2006
280
0.020
 Why?
Interleukin-6
1
2017
770
0.020
 Why?
Organ Specificity
1
2013
311
0.020
 Why?
Inhibitor of Apoptosis Proteins
1
2013
45
0.020
 Why?
Immune System
1
2014
178
0.020
 Why?
Lactation
1
2014
192
0.020
 Why?
Lipogenesis
1
2012
62
0.020
 Why?
Brain Neoplasms
2
1993
1327
0.020
 Why?
Point Mutation
1
1993
242
0.020
 Why?
Molecular Targeted Therapy
1
2015
437
0.020
 Why?
Neoplasms
2
2012
2873
0.020
 Why?
Tumor Necrosis Factor-alpha
2
2007
1207
0.020
 Why?
Astrocytoma
1
1993
129
0.020
 Why?
Broad Ligament
1
1991
1
0.020
 Why?
Gene Knockdown Techniques
1
2013
334
0.020
 Why?
Peritoneum
1
1991
44
0.020
 Why?
Mucins
1
1991
75
0.020
 Why?
Pregnancy Complications, Neoplastic
1
1991
63
0.020
 Why?
Blotting, Northern
1
2010
203
0.020
 Why?
Evaluation Studies as Topic
1
1991
164
0.020
 Why?
Hormones
1
1991
133
0.020
 Why?
Glycolysis
1
2012
341
0.020
 Why?
Cells, Cultured
2
2013
4110
0.020
 Why?
In Situ Hybridization
1
2010
318
0.020
 Why?
Soft Tissue Neoplasms
1
1991
128
0.020
 Why?
Precipitin Tests
1
1989
90
0.020
 Why?
Pilot Projects
1
2015
1886
0.020
 Why?
Pregnancy
2
2014
7122
0.020
 Why?
Radionuclide Imaging
1
1989
115
0.020
 Why?
Odds Ratio
1
1992
1076
0.020
 Why?
Glioblastoma
1
1993
353
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
751
0.020
 Why?
Risk Factors
1
2003
10796
0.020
 Why?
Protein Multimerization
1
2010
207
0.020
 Why?
Lymph Nodes
1
1991
501
0.020
 Why?
Drug Interactions
1
2009
401
0.020
 Why?
Cytochromes c
1
2007
52
0.020
 Why?
Membrane Potential, Mitochondrial
1
2007
74
0.020
 Why?
Apoptotic Protease-Activating Factor 1
1
2007
2
0.020
 Why?
Caspase 10
1
2006
5
0.020
 Why?
Caspase 2
1
2006
12
0.020
 Why?
Caspase 8
1
2006
47
0.020
 Why?
Amino Acid Sequence
3
1998
2136
0.020
 Why?
Caspase 9
1
2006
51
0.020
 Why?
Cysteine Endopeptidases
1
2006
69
0.020
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2006
17
0.020
 Why?
Caspase 7
1
2006
22
0.020
 Why?
Isoenzymes
1
2007
297
0.020
 Why?
Eukaryotic Initiation Factor-4E
1
2006
32
0.020
 Why?
Vero Cells
1
2006
84
0.010
 Why?
Cytosol
1
2006
214
0.010
 Why?
Biomarkers
1
2017
4261
0.010
 Why?
Base Sequence
2
2003
2177
0.010
 Why?
Promoter Regions, Genetic
1
2010
1246
0.010
 Why?
Virus Assembly
1
2006
81
0.010
 Why?
Taxoids
1
2004
116
0.010
 Why?
Protein Binding
1
2010
2243
0.010
 Why?
Protein Processing, Post-Translational
1
2006
466
0.010
 Why?
DNA, Complementary
1
2003
273
0.010
 Why?
Melanoma, Experimental
1
2003
109
0.010
 Why?
Americas
1
2002
26
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2002
25
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
78
0.010
 Why?
Endothelial Growth Factors
1
2002
62
0.010
 Why?
Lymphokines
1
2002
128
0.010
 Why?
Plasminogen Activator Inhibitor 1
1
2002
85
0.010
 Why?
Platelet Membrane Glycoproteins
1
2002
30
0.010
 Why?
Cell Adhesion
1
2003
452
0.010
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2002
49
0.010
 Why?
Gene Targeting
1
2002
80
0.010
 Why?
Exons
2
1993
362
0.010
 Why?
Mice, Inbred C57BL
2
2003
5967
0.010
 Why?
Europe
1
2002
419
0.010
 Why?
Templates, Genetic
1
2001
63
0.010
 Why?
Molecular Sequence Data
2
1998
2909
0.010
 Why?
Substrate Specificity
1
2002
392
0.010
 Why?
DNA, Superhelical
1
2000
12
0.010
 Why?
DNA Footprinting
1
2000
33
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2002
376
0.010
 Why?
Mice, Inbred BALB C
1
2003
1251
0.010
 Why?
Data Interpretation, Statistical
1
2002
368
0.010
 Why?
Genes, erbB
1
2000
2
0.010
 Why?
Ploidies
1
2000
20
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
117
0.010
 Why?
Macromolecular Substances
1
2000
219
0.010
 Why?
Pathology, Clinical
1
2000
29
0.010
 Why?
Vascular Endothelial Growth Factor A
1
2002
550
0.010
 Why?
Gene Silencing
1
2000
202
0.010
 Why?
Forecasting
1
2000
391
0.010
 Why?
Multicenter Studies as Topic
1
2000
408
0.010
 Why?
Genetic Therapy
1
2000
313
0.010
 Why?
Receptors, Cell Surface
1
2000
370
0.010
 Why?
Nucleic Acid Conformation
1
2000
728
0.010
 Why?
Binding Sites
1
2000
1307
0.010
 Why?
Chromosomes, Human, Pair 13
1
1996
15
0.010
 Why?
ras Proteins
1
1998
151
0.010
 Why?
Chromosomes, Human, Pair 3
1
1996
43
0.010
 Why?
Chromosomes, Human, Pair 11
1
1996
59
0.010
 Why?
Immunoblotting
1
1997
293
0.010
 Why?
Heterozygote
1
1996
313
0.010
 Why?
Hyaluronic Acid
1
1998
223
0.010
 Why?
Societies, Medical
1
2000
890
0.010
 Why?
Adenine
1
1998
337
0.010
 Why?
Polymorphism, Single-Stranded Conformational
1
1995
26
0.010
 Why?
Protein Isoforms
1
1997
396
0.010
 Why?
Melanoma
1
2002
757
0.010
 Why?
Cyclin D1
1
1995
63
0.010
 Why?
Factor VIII
1
1995
105
0.010
 Why?
Single-Blind Method
1
1995
319
0.010
 Why?
United States
2
2004
16018
0.010
 Why?
Observer Variation
1
1995
355
0.010
 Why?
Transcription, Genetic
1
2000
1468
0.010
 Why?
Randomized Controlled Trials as Topic
1
2000
1742
0.010
 Why?
Alleles
1
1996
886
0.010
 Why?
Biopsy
1
1995
1079
0.010
 Why?
Proliferating Cell Nuclear Antigen
1
1991
48
0.010
 Why?
Peripheral Nerves
1
1991
71
0.010
 Why?
DNA
1
1996
1447
0.000
 Why?
Polymorphism, Genetic
1
1993
613
0.000
 Why?
Risk Assessment
1
2000
3729
0.000
 Why?
Protein Conformation
1
1993
935
0.000
 Why?
Lung Neoplasms
1
2002
2660
0.000
 Why?
Cerebral Cortex
1
1991
470
0.000
 Why?
Glioma
1
1991
429
0.000
 Why?
Child
1
1993
22600
0.000
 Why?
Thor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (458) concept(s)
_
Co-Authors Expand Description
See all (24) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)